Invasive Carcinoma — Trials

Invasive Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,812 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 603
Recruiting: 301
Ph III recruiting: 36
Growth YoY: +27.2%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 51–100 of 1,812 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06205316	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma	active not recruiting	Phase 3	118	Mayo ClinicOTHER	1	Sep 17, 2026	clinicaltrials
NCT06733363	A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer	recruiting	Phase 2	344	Roswell Park Cancer InstituteOTHER	1	Sep 17, 2026	clinicaltrials